Related references
Note: Only part of the references are listed.Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
Antonio Vitiello et al.
RESPIRATORY MEDICINE (2021)
Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean
Mara Garcia-Posada et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies
Alexis E. Cullen et al.
LANCET PSYCHIATRY (2021)
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Lopes et al.
RMD OPEN (2021)
COVID-19 in kidney transplant recipients
Ilaria Gandolfini et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
Spyridon G. Deftereos et al.
HELLENIC JOURNAL OF CARDIOLOGY (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?
Spyridon Deftereos et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
Mirko Scarsi et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey L. Freeman et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial
Nooshin Dalili et al.
TRIALS (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Antonella Fara et al.
OPEN BIOLOGY (2020)
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
Luigi Brunetti et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The role of dysregulated immune responses in COVID-19 pathogenesis
S. Tahaghoghi-Hajghorbani et al.
VIRUS RESEARCH (2020)
A Retrospective Observational Study of Hypoxic COVID-19 Patients Treated with Immunomodulatory Drugs in a Tertiary Care Hospital
Nilesh Mahale et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2020)
Colchicine Pharmacokinetics and Mechanism of Action
Christos Angelidis et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Colchicine: an affordable anti-inflammatory agent for atherosclerosis
Peter L. Thompson et al.
CURRENT OPINION IN LIPIDOLOGY (2018)
Share Paper
